RECRUITING

TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Hypothesis: The investigators hypothesize that genetic variants will alter gene expression in response to ischemia during cardiopulmonary bypass. To test this, the investigators will be taking small pieces of heart tissue from patients undergoing heart surgery before and after this period of ischemia. This will be compared to blood gene expression in blood cells and analyzed with the patients' genetic profile. This might allow us to assess the amount of inflammation that occurs when patients are on the heart-lung machine as well as examine the effects genes have on this critical time period.

Official Title

Whole Genome Expression of Left Ventricular Myocardium During Cardiac Surgery

Quick Facts

Study Start:2009-03
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00985049

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged greater than 20 years
  2. * Undergoing aortic valve surgery with or without CABG surgery
  3. * Receive and apical vent as part of the surgery
  1. * Will not receive an apical left ventricular vent

Contacts and Locations

Study Contact

Jochen D Muehlschlegel, MD, MMSc, MBA
CONTACT
4109558408
dmuehlsch@jhu.edu

Principal Investigator

Jochen D. Muehlschlegel, MD, MMSc, MBA
PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Sergey Karamnov, MD
STUDY_DIRECTOR
Brigham and Women's Hospital

Study Locations (Sites)

Brigham and Women's Hospital
Boston, Massachusetts, 02115
United States

Collaborators and Investigators

Sponsor: Brigham and Women's Hospital

  • Jochen D. Muehlschlegel, MD, MMSc, MBA, PRINCIPAL_INVESTIGATOR, Johns Hopkins University
  • Sergey Karamnov, MD, STUDY_DIRECTOR, Brigham and Women's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2009-03
Study Completion Date2025-12

Study Record Updates

Study Start Date2009-03
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • Cardiovascular Diseases